1. Medtronic
$64 million in research payments to doctors and teaching hospitals (2018)
Big 100 rank: 1
2.7% of R&D spending ($2.33 billion)
0.2% of annual revenue ($30.557 billion)
Medtronic: Top doctor payments
The top five payments to doctors in the U.S. through Medtronic totaled $115,686 and went toward drug infusion and neurostimulation devices.
- $34,486 related to research studies involving the SynchroMed infusion system and Ascenda catheter;
- $27,032 related to SynchroMed and Ascenda research studies;
- $22,014 involving SynchroMed and Ascenda research studies;
- $21,672 associated with SynchroMed and Ascenda research studies;
- $10,481 for a spinal cord neurostimulation research study involving the Pisces, Vectris, PrimeAdvanced, Intellis and Specify devices.
Medtronic Minimed: Top doctor payments
The top five payments to doctors in the U.S. through subsidiary Medtronic Minimed totaled $108,312 and went toward research studies for the Minimed 670G insulin pump system and Enlite sensor.- $31,897 associated with a Minimed 670G System study;
- $30,340 related to a pediatrics study;
- $16,075 related to a Minimed 670G System study;
- $15,000 in two individual payments involving an Enlite continuous glucose monitoring study.
Medtronic USA: Top doctor payments
The top five payments to doctors in the U.S. through subsidiary Medtronic USA totaled $215,925 and went toward investigator-sponsored research in five individual payments of $56,190; $55,308; $53,800; $31,252 and $19,375.
Medtronic Vascular: Top doctor payments
The top five payments to doctors in the U.S. through subsidiary Medtronic Vascular totaled $66,461 and went toward implantable cardioverter defibrillator and cannula studies.
- $24,140 for a research study involving Bio-Medicus cannulae;
- $13,743 for a research study involving Viva cardiac resynchronization therapy–defibrillators (CRT-Ds);
- $10,557 related to Evera ICD research;
- $9,037 for Viva CRT-D research;
- $8,993 associated with Viva CRT-D research.
Medtronic: Top teaching hospital payments
The top five payments to teaching hospitals in the U.S. through Medtronic totaled $306,519 and went toward Attain, Sprint Quattro, Performa, Capsure lead studies and a Micra pacemaker study in five individual payments of $78,780; $75,495; $59,573; $46,450 and $46,221.
Medtronic Minimed: Top teaching hospital payments
The top five payments to teaching hospitals in the U.S. through subsidiary Medtronic Minimed totaled $13,163 and went toward Minimed 530G insulin pump research studies in five individual payments of $4,216; $3,866; $2,400; $1,431 and $1,250.
Medtronic USA: Top teaching hospital payments
The top five payments to teaching hospitals in the U.S. through subsidiary Medtronic USA totaled $134,455 and went toward laser ablation and stimulation devices.
- $40,000 involving a study of Visualase MRI-guided laser ablationy;
- $39,822 for a CD Horizon spinal system study;
- $24,741 related to a Visualase study;
- $17,045 associated with an Interstim sacral nerve stimulation study;
- $12,847 related to a Restore spinal cord neurostimulation study.
Medtronic Vascular: Top teaching hospital payments
The top five payments to teaching hospitals in the U.S. through subsidiary Medtronic Vascular totaled $669,596 and went toward transcatheter valve systems, antibacterial mesh and stent studies.
- $157,475 related to a study of CoreValve and Evolut TAVR;
- $132,830 associated with two individual payments for study of CoreValve and Evolut;
- $128,800 for a Tyrx antibacterial mesh study;
- $117,661 related to a Resolute stent study.